|
|
April 9, 2002
Fred Gage, Expert in Brain Regeneration,
Joins ALS Center
An internationally-recognized expert on regeneration of the nervous system
has become the newest member of the Scientific Advisory Board for the
Center for ALS Research at Johns Hopkins.
Fred Gage, Ph.D., is known for his work on the ability of natural agents
called trophic factors to protect the brain against insult and, more recently,
for his isolation of specific adult stem cells in the mammalian brain
and studies into their behavior.
Presently president of the Society for Neuroscience, this country's premier
neuro- research organization, Gage is a professor of laboratory genetics
at The Salk Institute for Biological Studies. He's a former professor
of neuroscience at the University of California, San Diego.
Gage has received many awards, including the 1993 Charles A. Dana Award
for Achievements in Health and Education, the Christopher Reeves Medal,
the Decade of the Brain Medal, the Max-Planck Research Prize and the Pasarow
Award. He received his doctoral degree from The Johns Hopkins University
in 1976, and a bachelor's degree from the University of Florida in 1972.
As a member of the Scientific Advisory Board, he'll generate new research
ideas, evaluate progress of the Center and appraise research proposals,
assuring that the Center funds only research of the highest merit.
THE CENTER FOR ALS RESEARCH
The Center for ALS Research at Johns Hopkins is a collaborative effort
by some of the best ALS and non-ALS scientists to aggressively and rapidly
develop new treatments and find a cure for ALS, also know as Lou Gehrig's
disease. It's the only institution of its kind dedicated solely to the
disease. Research conducted by the Center is meant to translate from bench
to bedside in a expedited time frame. Center scientists from institutions
around the world have made some of the most important discoveries in ALS,
leading to advances in understanding and treatment of the disease. The
nature of ALS shapes the Center's aggressive, results-oriented scientific
approach. ALS is a divesting, progressive neuromuscular disease that causes
complete paralysis and loss of function-including the ability to eat,
speak, and breathe-and eventually, death. ALS progresses quickly and is
not curable. Most patients die within five years of diagnosis.
|
|
|
|
| Recent news from the Robert Packard Center
for ALS Research: |
| In ALS, It’s Not the Number of Ailing Astrocytes That Counts - June 12, 2008 |
| Leaky Blood Vessels Add To ALS Damage, Could Offer New Repair Site - June 10, 2008 |
| William H. Adams Foundation Pumps New Energy, Funds into Search for ALS Cure - May 6, 2008 |
| Tell-Tale Protein Clumping in ALS is Less Complex Than Expected - April 10, 2008 |
ALS Mouse Study Highlights Astrocytes' Strong Potential as Therapy Target - February 7, 2008 |
| Exciting New Human ALS Trial: Lithium and Riluzole - February 7, 2008 |
| ALS Treatment: A Matter of Cleaning House? - December 19, 2007 |
New Study Brings What Goes Wrong in Inherited ALS into Focus - September 18, 2007 |
| New ALS Protein Could Be a Keystone - August 9, 2007 |
| Muscles More Than Passive Victims in ALS, Study Suggests - June 29, 2007 |
| Saer and O’Neill Named Packard Center Board Co-Chairs - June 28, 2007 |
Self-Attack? Self-Repair? First Real Look at Gene Activity in ALS Models Sparks Thirst for Answers - May 3, 2007 |
| Model of Accelerated Familial ALS Sheds Light on Disease Process - April 6, 2007 |
| Early News From First Large Search for Sporadic ALS Genes - February 20, 2007 |
| Human Stem Cell Transplants Mature Into Neurons and Make Contacts in Rat Spinal Cord - February 14, 2007 |
|
